From Office of TX Attorney General <[email protected]>
Subject Attorney General Ken Paxton Secures $720 Million from Drug Manufacturers for their Role in the Catastrophic Opioid Epidemic
Date August 29, 2025 3:51 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Seal
________________________________________________________________________





*FOR IMMEDIATE RELEASE*

August 29, 2025

www.texasattorneygeneral.gov




*PRESS OFFICE: (512) 463-2050*

[email protected]





 

*Attorney General Ken Paxton Secures $720 Million from Drug Manufacturers for their Role in the Catastrophic Opioid Epidemic *

 

AUSTIN – Attorney General Ken Paxton secured a new opioid settlement worth $720 million with eight drug makers that manufactured opioid pills and worsened the nationwide opioid crisis. In partnership with State Attorneys General across the country, this settlement will allow all local governments to participate through a sign-on period. The State of Texas and its political subdivisions could receive up to $45.5 million. 

 

“These manufacturers played a role in creating one of the most destructive public health crises our country has ever faced,” said Attorney General Paxton. “These settlements are an important step in holding companies accountable for their reckless greed and the part they had in worsening the opioid epidemic, which has devastated our communities and poisoned countless Texans.” 

 

The eight defendants and the total amount they will pay in funds to address the opioid crisis as part of the deal are: 


* Mylan (now a part of Viatris): $284,447,916 paid over nine years 

* Hikma: $95,818,293 paid over one to four years 

* Amneal: $71,751,010 paid over 10 years 

* Apotex: $63,682,369 paid in a single year 

* Indivior: $38,022,450 paid over four years 

* Sun: $30,992,087 paid over one to four years 

* Alvogen: $18,680,162 paid in a single year 

* Zydus: $14,859,220 paid in a single year 

In addition to these abatement payments, the companies have also agreed to injunctive relief. Seven of the companies—not including Indivior—are prohibited from promoting or marketing opioid products, from making or selling any product that contains more than 40 mg of oxycodone per pill, and are required to put in place a monitoring and reporting system for suspicious orders. Indivior, for its part, has agreed to not manufacture or sell opioid products for the next 10 years, but it will be able to continue marketing and selling medications to treat opioid use disorder. 

 

Including this new settlement, Attorney General Paxton has obtained settlements [ [link removed] ] committing nearly $3.34 billion in funds for Texas from companies that helped fuel the catastrophic opioid crisis.  

 

   

###







Stay Connected with Office of Texas Attorney General on
Facebook [ [link removed] ] - X [ [link removed] ] - Instagram [ [link removed] ] - Email [ [link removed] ]

 Update your subscriptions, modify your password or email address, or stop subscriptions at any time on your Subscriber Preferences Page [ [link removed] ]. You will need to use your email address to log in. If you have questions or problems with the subscription service, please visit subscriberhelp.govdelivery.com [ [link removed] ].


________________________________________________________________________

This email was sent to [email protected] using GovDelivery Communications Cloud on behalf of: Office of Texas Attorney General ·300 W. 15th Street · Austin, TX 78701 GovDelivery logo [ [link removed] ]
Screenshot of the email generated on import

Message Analysis